Herb & supplement monograph

Soy Drug Interactions, Uses, Effectiveness, Safety & More

Check Soy against your medication

Add one medication
Soy
+
Start typing any prescription or over-the-counter drug name.
Reviewed by licensed pharmacists Sourced from Natural Medicines

Soy Drug Interactions: The Bottom Line

From the HelloPharmacist Editorial Team · Updated July 2026

Based on the available evidence, the overall risk of a clinically significant Soy drug interaction appears low for most people. Only a small handful of the listed interactions are rated major, and most of the moderate ones rest on theoretical or limited human evidence.

Interactions deserving the most attention

The clearest concern is with MAOIs, a class of antidepressants: fermented soy foods like tofu and soy sauce contain tyramine, which these drugs stop the body from breaking down, raising the risk of a dangerous blood pressure spike. Soy may also reduce absorption of levothyroxine, an effect seen in infants given soy formula, and it can lower blood sugar, which could add to the effect of diabetes medications. There is also a single report of soy milk weakening warfarin's blood-thinning effect, so people on warfarin should watch for changes.

What the rest of the list means

Soy appears alongside hundreds of medications, but a long list does not mean every combination is harmful. Most entries come from lab or animal research or from possible effects on enzymes the body uses to clear medications. In fact, when one of these predicted enzyme effects was tested in people, medication levels did not change in a meaningful way.

Check your medications against Soy

Based on HelloPharmacist’s Soy interaction data and reviewed under our editorial standards.

Interaction report

Drugs that interact with Soy

612 medications have a known interaction with Soy, graded by severity. Select any drug for the full evidence-based detail.

9 major interactions. These combinations can be clinically significant — best avoided, or used only with close professional supervision. Always check with your pharmacist before combining them with Soy.

2,830 drugs
AmphetamineAdensys XR-ODT, Adzenys ER, Dyanavel XR, Mydayis› IsocarboxazidMarplan› MoclobemideManerix, Moclobemide› Ozanimod HydrochlorideZeposia› Phenelzine SulfateNardil› RasagilineAzilect› Safinamide MesylateXadago› SelegilineCarbex, Eldepryl, Emsam, Zelapar› TranylcypromineParnate› AcarboseGlucobay, Prandase, Precose› AcebutololRhotral, Sectral› Acetaminophen, Aspirin, CaffeineExcedrin, Excedrin Extra Strength, Excedrin Migraine› Acetaminophen, Butalbital, CaffeineEsgic, Esgic Plus, Fiogesic, Fioricet, Repan, Tecnal +1 more› Acetaminophen, Butalbital, Caffeine, CodeineEsgic with Codeine, Fioricet w/ Codeine› Acetaminophen, Caffeine, Chlorpheniramine, Hydrocodone, PhenylephrineHycomine Compound› Acetaminophen, Caffeine, CodeineGesic C15, Gesic C30, Gesic C8, Lenoltec 1, Lenoltec 2, Lenoltec 3 +1 more› Acetaminophen, Caffeine, Codeine, SalicylamideCodalan No.1, Codalan No.2, Codalan No.3› Acetaminophen, Caffeine, DihydrocodeineDHC Plus, Panlor DC, Panlor SS› Acetaminophen, Caffeine, IsomethepteneMigralam› Acetaminophen, Caffeine, PyrilamineMidol Max Strength Menstrual› Acetaminophen, Pamabrom, PyrilamineMidol Max Strength PMS, Pamprin, Pamprin ES› AcetazolamideAk-Zol, Diamox› AcetohexamideDymelor› AlbiglutideTanzeum› AliskirenTekturna› AlogliptinNesina› Alogliptin, MetforminKazano› Alogliptin, PioglitazoneOseni› AmbrisentanLetairis, Volibris› AmilorideAmilamont, Midamor›
Read The List Like a Pharmacist

What Severity, Likelihood & Evidence Mean

Severity — How Serious It Can Be

  • Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
  • Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
  • Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
  • No known interaction. Checked against our sources with nothing documented — not the same as proven safety.

Likelihood — How Well It’s Documented

  • Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
  • Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
  • Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
  • Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.

Where This Data Comes From

  • Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
  • Each drug listed above links to the full report for that exact Soy combination — clinical detail, likelihood, evidence level, and citations.
  • Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The big picture

The kinds of drugs Soy affects

Every type of medication (drug category) Soy is known to interact with. Open any category for the detail — or search your exact drug in the checker above.

All 12 drug categories Soy interacts with
Monoamine Oxidase Inhibitors (maois)Antidiabetes DrugsAntihypertensive DrugsCaffeineDiuretic DrugsEstrogensLevothyroxine (synthroid, Others)ProgesteroneTamoxifen (nolvadex)Warfarin (coumadin)Antibiotic DrugsCytochrome P450 2c9 (cyp2c9) Substrates
Monoamine Oxidase Inhibitors (Maois)

Taking soy products containing high amounts of tyramine along with MAOIs can increase the risk of hypertensive crisis.
Fermented soy products such as tofu and soy sauce contain tyramine, a naturally occurring chemical that affects blood pressure regulation. The metabolism of tyramine is decreased by MAOIs. Consuming more than 6 mg of tyramine while taking an MAOI can increase the risk of hypertensive crisis. The amount of tyramine in fermented soy products is usually less than 0.6 mg per serving; however, there can be significant variation depending on the specific product used, storage conditions, and length of storage. Storing one brand of tofu for a week can increase tyramine content from 0.23 mg to 4.8 mg per serving. Advise patients taking MAOIs to avoid fermented soy products that contain high amounts of tyramine.

Likelihood Likely Evidence C
Antidiabetes Drugs

Soy can lower blood glucose and have additive effects with antidiabetes drugs.
Clinical research shows that whole soy diets and soy-based meals reduce fasting glucose levels in diabetic and non-diabetic individuals. Also, individuals following a soy-based meal replacement plan seem to require lower doses of sulfonylureas and metformin to manage blood glucose levels when compared with individuals following a diet plan recommended by the American Diabetes Association.

Likelihood Possible Evidence A
Antihypertensive Drugs

Theoretically soy protein may have additive effects with antihypertensive drugs and increase the risk of hypotension.
Although some contradictory research exists, most clinical evidence suggests that consuming soy protein modestly reduces systolic and diastolic blood pressure in individuals with prehypertension or hypertension.

Likelihood Possible Evidence A
Caffeine

Theoretically, soy might reduce the clearance of caffeine.
Soy contains genistein. Taking genistein 1 gram daily for 14 days seems to inhibit caffeine clearance and metabolism in healthy females. This effect has been attributed to inhibition of the cytochrome P450 1A2 (CYP1A2) enzyme, which is involved in caffeine metabolism. It is unclear if this effect occurs with the lower amounts of genistein found in soy.

Likelihood Possible Evidence D
Diuretic Drugs

Theoretically, soy might have additive effects when used with diuretic drugs.
Animal research suggests that genistein, a soy isoflavone, increases diuresis within 6 hours of subcutaneous administration in rats. The effects seem to be similar to those of furosemide. This effect has not been reported in humans.

Likelihood Possible Evidence D
Estrogens

Theoretically, soy might competitively inhibit the effects of estrogen replacement therapy.
Soy contains phytoestrogens and has been shown to have estrogenic activity in some patients. Although this has not been demonstrated in humans, theoretically, concomitant use of soy with estrogen replacement therapy might reduce the effects of the estrogen replacement therapy.

Likelihood Possible Evidence D
Levothyroxine (Synthroid, Others)

Soy products might reduce the absorption of levothyroxine in some patients.
Preliminary clinical research and a case report suggest that soy-based formulas inhibit the absorption of levothyroxine in infants with congenital hypothyroidism. A levothyroxine dosage increase may be needed for infants with congenital hypothyroidism while using soy-based formulas, and the dose may need to be reduced when soy-based formulas are no longer administered. However, in postmenopausal adults, clinical research shows that taking a single dose of soy extract containing isoflavones 60 mg along with levothyroxine does not affect the oral bioavailability of levothyroxine.

Likelihood Possible Evidence B
Progesterone

Theoretically, combining soy isoflavones with transdermal progesterone may worsen bone density.
Clinical research suggests that significant bone loss may occur in females with osteoporosis who receive a combination of transdermal progesterone with soy milk containing isoflavones when compared with placebo, soy milk alone, or progesterone alone.

Likelihood Possible Evidence A
Tamoxifen (Nolvadex)

Theoretically, estrogenic soy isoflavones might alter the effects of tamoxifen.
Laboratory research suggests that genistein and daidzen, isoflavones from soy, can antagonize the antitumor effects of tamoxifen under some circumstances; however, soy isoflavones might have different effects when used at different doses. A relatively low in vitro concentration of soy isoflavones such as 1 microM/L seems to interfere with tamoxifen, whereas high in vitro concentrations such as those >10 microM/L might actually enhance tamoxifen effects. People on a high-soy diet have soy isoflavones levels ranging from 0.1-6 microM/L. Until more is known, advise patients taking tamoxifen to avoid therapeutic use of soy products.

Likelihood Possible Evidence B
Warfarin (Coumadin)

Theoretically, soy might interfere with the effects of warfarin.
Soy milk has been reported to decrease the international normalized ratio (INR) in a patient taking warfarin. The mechanism of this interaction is not known. However, animal and in vitro research suggests that soy may also inhibit platelet aggregation. Dosing adjustments for warfarin may be necessary.

Likelihood Possible Evidence D
Antibiotic Drugs

Theoretically, antibiotics may decrease the activity of soy isoflavones.
Intestinal bacteria are responsible in part for converting soy isoflavones into their active forms. Antibiotics may decrease the amount of intestinal bacteria and decrease its ability to convert isoflavones.

Likelihood Possible Evidence D
Cytochrome P450 2C9 (Cyp2C9) Substrates

Soy might modestly induce CYP2C9 enzymes. However, this effect does not seem to be clinically significant.
In vitro research suggests that an unhydrolyzed soy extract might induce CYP2C9. However, the significance of this interaction is likely minimal. In healthy females taking a specific extract of soy (Genistein Soy Complex, Source Naturals), blood levels of losartan, a CYP2C9 substrate, were not significantly affected.

Likelihood Unlikely Evidence D
Monograph

Soy: Uses, Safety & Side Effects

The bottom line

Soy is a nutritious bean that is a staple food and a popular source of plant protein and isoflavones. Eating soy foods as part of a balanced diet is generally considered safe for most people, and there is moderate evidence it may modestly help cholesterol and some menopause symptoms, though results vary. Talk with your pharmacist or doctor before using concentrated soy isoflavone supplements, especially if you have a history of hormone-sensitive conditions.

Scientific name
Glycine max
Family
Fabaceae
Part used
Bean (seed)
Common forms
Whole soybeans, soy milk, tofu, tempeh, edamame, soy protein powder, isoflavone capsules, soy lecithin
People commonly use it for
  • Menopause symptoms (hot flashes)
  • Heart and cholesterol health
  • Bone health
  • Plant-based protein source
  • General nutrition

Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.

Safety at a glance
OverallUse caution

Soy foods are generally safe for most people, but concentrated isoflavone supplements deserve more caution.

PregnancyLikely Safe

When used orally in amounts commonly found in foods.

Read the full pregnancy detail
BreastfeedingLikely Safe

When used orally in amounts commonly found in foods. A single 20-gram dose of roasted soybeans, containing 37 mg isoflavones, produces four to six tim...

Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Jump to a section

Overview

Soy comes from the soybean, the seed of the plant Glycine max, which is part of the legume (bean) family. Soybeans have been grown and eaten in East Asia for thousands of years and are now one of the most widely produced crops in the world.

Soy is found in many foods, such as tofu, tempeh, edamame, soy milk, and soy protein powders. It is also sold as dietary supplements, often standardized to contain plant compounds called isoflavones. People use soy both as a healthy source of plant protein and for possible health benefits like easing menopause symptoms and supporting heart health.

How it works

Soy contains isoflavones, mainly genistein and daidzein. These are sometimes called phytoestrogens because they are plant compounds that can weakly attach to estrogen receptors in the body. This is why soy is studied for menopause and other hormone-related effects.

Soy is also rich in high-quality protein, fiber, and healthy fats. The protein and fiber may help explain its possible effects on cholesterol. Some people can convert daidzein into a compound called equol, and this ability may affect how much benefit they get—though this is still being researched.

Much of what we know about how isoflavones act in the body comes from laboratory and animal studies, so the real-world effects in people are not fully understood.

Effectiveness

Does Soy work?

Evidence overview · 55 uses evaluated
11 Possibly effective 2 Leans ineffective 42 Insufficient evidence
How to read these evidence grades

Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.

1EffectiveStrong, consistent evidence it works.
2Likely EffectiveGood evidence, though not yet conclusive.
3Possibly EffectiveSome evidence suggests a benefit.
4Possibly IneffectiveSome evidence it may not help.
5Likely IneffectiveFairly strong evidence it doesn’t help.
6IneffectiveStrong evidence it doesn’t work.
7Insufficient Reliable Evidence to RateToo little research to say either way.
Possibly Effective Chronic kidney disease (CKD)
Rating & evidence shown verbatim from Natural Medicines

Oral soy protein seems to reduce proteinuria in patients with CKD. However, findings on other measures of CKD severity are conflicting.

Possibly Effective Diabetes
Rating & evidence shown verbatim from Natural Medicines

Diets high in soy seem to reduce the risk of type 2 diabetes. Also, oral soy protein, but not soy isoflavones, seems to modestly improve glycemic indices. It is unclear if soy is beneficial for lowering blood lipid levels or reducing cardiovascular (CVD) mortality risk in adults with type 2 diabetes.

Possibly Effective Diarrhea
Rating & evidence shown verbatim from Natural Medicines

Oral soy fiber seems to reduce acute diarrhea in infants, although it may not be beneficial in adults.

Possibly Effective Galactosemia
Rating & evidence shown verbatim from Natural Medicines

Oral soy protein can be used in infant formula to prevent symptoms of galactosemia.

Possibly Effective Hyperlipidemia
Rating & evidence shown verbatim from Natural Medicines

Oral soy protein seems to modestly reduce lipid levels. However, purified soy isoflavone may not have the same benefit.

Possibly Effective Hypertension
Rating & evidence shown verbatim from Natural Medicines

Oral soy seems to modestly reduce blood pressure in some patients.

Possibly Effective Lactose intolerance
Rating & evidence shown verbatim from Natural Medicines

Oral soy protein can be used in infant formula to prevent symptoms of lactose intolerance.

Possibly Effective Menopausal symptoms
Rating & evidence shown verbatim from Natural Medicines

Oral soy seems to reduce hot flashes in adults with menopausal symptoms.

Possibly Effective Metabolic syndrome
Rating & evidence shown verbatim from Natural Medicines

Oral soy protein seems to improve glycemic control and other markers of metabolic syndrome.

Possibly Effective Muscle strength
Rating & evidence shown verbatim from Natural Medicines

Oral soy protein seems to increase muscle strength.

Possibly Effective Osteoporosis
Rating & evidence shown verbatim from Natural Medicines

Oral soy isoflavones seem to improve bone density and reduce the risk of osteoporosis in postmenopausal adults.

Possibly Ineffective Benign prostatic hyperplasia (BPH)
Rating & evidence shown verbatim from Natural Medicines

Oral soy does not seem to reduce BPH symptoms.

Possibly Ineffective Breast cancer-related hot flashes
Rating & evidence shown verbatim from Natural Medicines

Oral soy does not seem to reduce the risk for breast cancer-related hot flashes.

Also studied for 42 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Alzheimer disease
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy improves cognition in patients with Alzheimer disease.

Insufficient Reliable Evidence To Rate Androgen deprivation therapy (ADT)-associated hot flashes
Rating & evidence shown verbatim from Natural Medicines

One small clinical study in patients with prostate cancer receiving ADT shows that taking soy protein powder 20 grams, providing 160 mg of isoflavones, alone or along with venlafaxine 75 mg, once daily for 12 weeks does not improve the severity of hot flash symptoms when compared with milk protein, with or without venlafaxine.

Sources Ref 90981
Insufficient Reliable Evidence To Rate Asthma
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces asthma symptoms.

Insufficient Reliable Evidence To Rate Cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if soy consumption reduces the risk of cancer.

Insufficient Reliable Evidence To Rate Cardiovascular disease (CVD)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if soy consumption reduces the risk for CVD or CVD-related mortality.

Insufficient Reliable Evidence To Rate Cervical cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces the risk for cervical cancer.

Insufficient Reliable Evidence To Rate Child growth
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy protein enhances child growth.

Insufficient Reliable Evidence To Rate Cognitive function
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy improves cognitive function; research is conflicting.

Insufficient Reliable Evidence To Rate Cognitive impairment
Rating & evidence shown verbatim from Natural Medicines

Oral soy has only been evaluated in combination with other ingredients; its effect when used alone is unclear.

Insufficient Reliable Evidence To Rate Colic
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy is beneficial in infants with colic.

Insufficient Reliable Evidence To Rate Colorectal cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if higher soy intakes reduce the risk for colorectal cancer. Study results are conflicting.

Insufficient Reliable Evidence To Rate Crohn disease
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy improves symptoms of Crohn disease.

Insufficient Reliable Evidence To Rate Diabetic nephropathy
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy improves kidney function in patients with diabetic nephropathy.

Insufficient Reliable Evidence To Rate Dyspepsia
Rating & evidence shown verbatim from Natural Medicines

Oral soy protein has only been evaluated in combination with other ingredients; its effect when used alone is unclear.

Insufficient Reliable Evidence To Rate Endometrial cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy protein reduces the risk for endometrial cancer.

Insufficient Reliable Evidence To Rate Exercise-induced muscle soreness
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces muscle soreness after exercise.

Insufficient Reliable Evidence To Rate Fibromyalgia
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces fibromyalgia symptoms.

Insufficient Reliable Evidence To Rate Food allergies
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy prevents food allergies.

Insufficient Reliable Evidence To Rate Frailty
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy helps prevent or slow frailty in older adults.

Insufficient Reliable Evidence To Rate Gastric cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces the risk for gastric cancer.

Insufficient Reliable Evidence To Rate Hepatitis C
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy is beneficial for hepatitis C.

Insufficient Reliable Evidence To Rate Irritable bowel syndrome (IBS)
Rating & evidence shown verbatim from Natural Medicines

A small study suggests that oral soy isoflavones might reduce IBS symptoms.

Insufficient Reliable Evidence To Rate Lung cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if dietary soy reduces the risk for lung cancer.

Insufficient Reliable Evidence To Rate Mastalgia
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy is beneficial for mastalgia.

Insufficient Reliable Evidence To Rate Metabolic dysfunction-associated steatotic liver disease (MASLD)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy is beneficial for the treatment or prevention of MASLD, previously called nonalcoholic fatty liver disease (NAFLD)..

Insufficient Reliable Evidence To Rate Migraine headache
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy is beneficial for the treatment or prevention of migraine.

Insufficient Reliable Evidence To Rate Neonatal jaundice
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces the risk of neonatal jaundice.

Insufficient Reliable Evidence To Rate Nephrotic syndrome
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using oral soy for nephrotic syndrome, there is insufficient reliable information about the clinical effects of soy for this purpose.

Insufficient Reliable Evidence To Rate Obesity
Rating & evidence shown verbatim from Natural Medicines

It is unclear if consuming oral soy protein as part of a calorie-restricted diet improves weight loss; research is conflicting.

Insufficient Reliable Evidence To Rate Osteoarthritis
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy protein reduces osteoarthritis pain.

Insufficient Reliable Evidence To Rate Overall mortality
Rating & evidence shown verbatim from Natural Medicines

It is unclear if dietary soy reduces overall mortality; the available research is conflicting.

Insufficient Reliable Evidence To Rate Polycystic ovary syndrome (PCOS)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces PCOS symptoms.

Insufficient Reliable Evidence To Rate Postmenopausal conditions
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy is beneficial for postmenopausal conditions.

Insufficient Reliable Evidence To Rate Premenstrual syndrome (PMS)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces PMS symptoms.

Insufficient Reliable Evidence To Rate Preterm labor
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces the risk for preterm labor.

Insufficient Reliable Evidence To Rate Prostate cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy is beneficial for the treatment or prevention of prostate cancer; research is conflicting.

Insufficient Reliable Evidence To Rate Rheumatoid arthritis (RA)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces RA symptoms.

Insufficient Reliable Evidence To Rate Sarcopenia
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy reduces age-related muscle loss; evidence is conflicting.

Insufficient Reliable Evidence To Rate Stroke
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral soy improves outcomes and overall function in people who have had a stroke.

Insufficient Reliable Evidence To Rate Thyroid cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if dietary soy reduces the risk for thyroid cancer.

Insufficient Reliable Evidence To Rate Vaginal atrophy
Rating & evidence shown verbatim from Natural Medicines

It is unclear if topical soy improves vaginal atrophy.

Insufficient Reliable Evidence To Rate Wrinkled skin
Rating & evidence shown verbatim from Natural Medicines

Small studies suggest that oral and topical soy might reduce wrinkles.

Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.

Safety & precautions

Soy foods have a long history of safe use and are eaten daily by millions of people. For most healthy adults, including soy as part of a balanced diet is considered safe.

More caution is needed with concentrated isoflavone supplements, which provide much higher amounts than food. People with a personal or family history of hormone-sensitive conditions (such as breast cancer) should talk with their doctor before using soy supplements, since the hormone-like effects are not fully understood. People with thyroid problems should also be cautious, as very high soy intake may affect thyroid function in some cases.

For pregnancy, eating soy foods in normal amounts is likely fine, but high-dose isoflavone supplements should be avoided unless your doctor approves. For breastfeeding, soy foods are commonly eaten, but concentrated supplements have not been well studied, so caution is best. Soy is also a common food allergen—anyone with a soy allergy should avoid it.

Side effects

Soy is usually well tolerated. The most common side effects are mild and related to digestion, such as bloating, gas, constipation, or stomach upset.

Some people are allergic to soy, which can cause itching, hives, swelling, or, rarely, a serious allergic reaction (anaphylaxis). Seek emergency care for trouble breathing or throat swelling. High doses of isoflavone supplements may rarely cause hormone-related effects, which is why supplements deserve more caution than food.

Soy: Reported Adverse Effects

Documented safety reports on Soy from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.

Orally, soy is well tolerated.

Most Common Adverse Effects:

Orally: Bloating, constipation, diarrhea, and nausea.

All ROAs: Allergic reactions.

Reports by condition
Allergic rhinitis (hay fever) Pulmonary/Respiratory
Allergic rhinitis (hay fever) Immunologic

Orally, soy can cause allergic reactions such as skin rash and itching in some people. In an 11-year-old female, allergy to soy protein resulting in a delayed itching papular rash was thought to be responsible for the reaction to injected benzathine benzylpenicillin containing possible soy protein-contaminated soy lecithin.

Topically, soy-based ingredients were responsible for the development of hand atopic dermatitis in a young female using cosmetic lotions in the workplace. Percutaneous sensitization resulted in the development of anaphylaxis to oral soy.

  1. Teixeira SR, Potter SM, Weigel R, et al. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000;71:1077-84.
  2. Barni S, Mori F, Pantano S, Novembre E. Adverse reaction to benzathine benzylpenicillin due to soy allergy: a case report. J Med Case Rep. 2015;9:134.
  3. Yagami A, Suzuki K, Nakamura M, et al. Case of anaphylactic reaction to soy following percutaneous sensitization by soy-based ingredients in cosmetic products. J Dermatol. 2015;42(9):917-8.
Bladder cancer Oncologic

There is controversy about the role of soy in breast cancer. Population studies suggest that soy is protective against breast cancer. Asian females who eat a traditional diet high in soy seem to have a lower risk of developing breast cancer. Early exploratory studies have suggested that soy stimulates proliferation of normal human breast tissue. However, taking a soy tablet containing 50 mg soy isoflavones daily for 12 months does not alter mammographic or breast MRI tissue density in adults at high risk of breast cancer, with non-endocrine treated breast cancer, or previously treated for breast cancer and without evidence of recurrence.

There is some concern that soy supplements, but not soy foods, might increase the risk of endometrial hyperplasia due to its estrogenic effects. Population and clinical research suggests that soy foods do not have a proliferative effect on endometrial cells, and increased dietary soy and phytoestrogens are associated with reduced endometrial cancer risk. However, the effects seem to be different with concentrated soy isoflavone extract. While taking products providing isoflavones 120 mg daily for 6 months does not increase endometrial thickening, taking higher doses such as isoflavones 150 mg daily for 5 years might increase the risk of simple endometrial hyperplasia. However, there is no evidence that soy isoflavones increase the risk of atypical hyperplasia which has a much higher risk of developing into endometrial cancer than simple endometrial hyperplasia.

There is also concern that increased soy intake increases the risk for other types of cancer. Some observational research has found that higher dietary intake of soy is associated with a higher risk for bladder cancer and pancreatic cancer.

A meta-analysis of results from cohort and case-control studies evaluating the risk of stomach cancer related to consumption of fermented soy products is unclear and inconclusive. The highest quality data from cohort studies suggests that these products have no significant effect on stomach cancer. More research is required to determine if soy products have any correlation with stomach cancer.

  1. Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 2000;71:1705S-7S.
  2. Murkies A, Dalais FS, Briganti EM, et al. Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause 2000;7:289-96.
  3. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-27..
  4. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998;68:1431S-5S.
  5. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5:785-94.
  6. Wu AH, Spicer D, Garcia A, et al. Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density. Cancer Prev Res (Phila). 2015;8(10):942-51.
  7. Foth D, Cline JM. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 1998;68:1413S-7S.
  8. Lu LJ, Anderson KE, Grady JJ, et al. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 2000;60:4112-21.
  9. Duncan AM, Merz BE, Xu X, et al. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999;84:192-7.
  10. Brown BD, Thomas W, Hutchins A, et al. Types of dietary fat and soy minimally affect hormones and biomarkers associated with breast cancer risk in premenopausal women. Nutr Cancer 2002;43:22-30..
  11. Balk JL, Whiteside DA, Naus G, et al. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig 2002;9:238-42..
  12. Goodman MT, Wilkens LR, Hankin JH, et al. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 1997;146:294-306.
  13. Horn-Ross PL, John EM, Canchola AJ, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003;95:1158-64..
  14. Kaari C, Haidar MA, Junior JMS, et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 2006;53:49-58.
  15. Unfer V, Casini ML, Costabile L, et al. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 2004;82:145-8.
  16. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones. EFSA J. 2015;13(10):4246.
  17. Sun CL, Yuan JM, Arakawa K, et al. Dietary soy and increased risk of bladder cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2002;11:1674-7.
  18. Yamagiwa Y, Sawada N, Shimazu T, et al. Soy Food Intake and Pancreatic Cancer Risk: The Japan Public Health Center-based Prospective Study. Cancer Epidemiol Biomarkers Prev. 2020;29(6):1214-1221.
  19. Wu AH, Yang D, Pike MC. A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev 2000;9:1051-8.
  20. Ji BT, Chow WH, Yang G, et al. Correspondence re: AH Wu et al, A meta-analysis of soyfoods and risk of stomach cancer: the problem of potential confounders. Cancer Epidemiol Biomarkers Prev 2001;10:570.
Cognitive function Neurologic/CNS

Orally, one clinical study showed that insomnia was more common in postmenopausal adults taking soy isoflavone supplements when compared with those receiving placebo.

Some research suggests that dietary consumption of tofu during midlife might decrease cognitive function in later years. Evidence from one retrospective cohort study suggests that males who consume at least two servings of tofu weekly during midlife have increased risk of cognitive impairment in late life (19% vs. 4%) compared to those who consume tofu less frequently. Although the effect of tofu was considered to be marginal compared to other factors such as age, education, or history of stroke, results from the study suggest that the effect of significant midlife consumption of tofu is comparable to the effect of an age difference of 4 years or an education difference of 3 years. However, numerous other factors, such as lifestyle and health, could be involved. Therefore, these findings are too preliminary to be used as a basis for clinical recommendations.

  1. Balk JL, Whiteside DA, Naus G, et al. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig 2002;9:238-42..
  2. White LR, Petrovitch H, Ross GW, et al. Brain aging and midlife tofu consumption. J Am Coll Nutr 2000;19:242-55.
  3. Grodstein F, Mayeux R, Stampfer MJ. Tofu and cognitive function: food for thought. J Am Coll Nutr 2000;19:207-9.
Constipation Endocrine

In the 1950s and 1960s, cases of altered thyroid function, particularly goiter, were reported in children taking soy formula. However, adding iodine to soy formula or replacing soy flour in formula with soy protein isolate has nearly eliminated the risk of altered thyroid function in most infants.

In adults, there is some evidence that soy intake can alter thyroid function. Results from one clinical trial suggests that consuming soybeans 30 grams daily for as little as one month can increase thyroid-stimulating hormone (TSH) and decrease thyroxine, causing diffuse goiters, constipation, fatigue, and lethargy in some Japanese men. Recovery was achieved by discontinuing soybean intake. There is also some evidence that soy inhibits thyroid hormone synthesis resulting in increased secretion of TSH in some postmenopausal patients. However, this seems to only occur in people with iodine deficiency. In postmenopausal patients with normal levels of iodine, taking a soy extract for 6 months does not seem to significantly affect thyroid hormone levels.

Evidence from a single case-control study suggests that consumption of soy-based formulas may be associated with an observed three-fold increase in the risk of breast development in Puerto Rican children less than 2 years-old. The correlation has been attributed to the estrogenic activity of soy. However, other risk factors, including a maternal history of ovarian cysts and consumption of meat products were also associated with the increased risk of breast development prior to 2 years of age. Also, the investigators noted that in over half of the cases, the child had not been exposed to soy or any of the other risk factors. Therefore, factors other than soy consumption may be more strongly associated with the increased risk of breast development prior to 2 years of age.

  1. Rozman, K. K., Bhatia, J., Calafat, A. M., Chambers, C., Culty, M., Etzel, R. A., Flaws, J. A., Hansen, D. K., Hoyer, P. B., Jeffery, E. H., Kesner, J. S., Marty, S., Thomas, J. A., and Umbach, D. NTP-CERHR expert panel report on the reproductive and dev
  2. Van Wyk JJ, Arnold MB, Wynn J, and et al. The effects of a soybean product on thyroid function in humans. Pediatrics 1959;24:752-760.
  3. Fitzpatrick, M. Soy formulas and the effects of isoflavones on the thyroid. N.Z.Med J 2-11-2000;113(1103):24-26.
  4. Persky VW, Turyk ME, Wang L, et al. Effect of soy protein on endogenous hormones in postmenopausal women. Am J Clin Nutr 2002;75:145-53.
  5. Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol 1997;54:1087-96.
  6. Messina, M. and Redmond, G. Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid 2006;16(3):249-258.
  7. Bruce B, Messina M, Spiller G. Isoflavone supplements do not affect thyroid function in iodine-replete postmemopausal women. J Med Food 2003;6:309-16.
  8. Freni-Titulaer, L. W., Cordero, J. F., Haddock, L., Lebron, G., Martinez, R., and Mills, J. L. Premature thelarche in Puerto Rico. A search for environmental factors. Am.J Dis.Child 1986;140(12):1263-1267.
Constipation Gastrointestinal

Gastrointestinal upset, such as constipation, diarrhea, bloating, and nausea are the most common side effects of soy. Reports of "bad taste" and taste intolerance have also been documented in clinical research. Firmer stools, diarrhea, colitis, and intestinal mucosal damage has been reported in infants fed soy protein formula.

  1. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
  2. Kumar NB, Cantor A, Allen K et al. The specific role of isoflavones in reducing prostate cancer risk. Prostate 2004;59:141-7.
  3. Chen YM, Ho SC, Lam SS, et al. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4740-7.
  4. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104:824-36.
  5. Clement, Y. N., Onakpoya, I., Hung, S. K., and Ernst, E. Effects of herbal and dietary supplements on cognition in menopause: a systematic review. Maturitas 2011;68(3):256-263.
  6. Wu AH, Spicer D, Garcia A, et al. Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density. Cancer Prev Res (Phila). 2015;8(10):942-51.
  7. Whelan, A. M., Jurgens, T. M., and Naylor, H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can.J.Clin.Pharmacol. 2009;16(3):e407-e429.
  8. Hill, D. J., Heine, R. G., Cameron, D. J., Francis, D. E., and Bines, J. E. The natural history of intolerance to soy and extensively hydrolyzed formula in infants with multiple food protein intolerance. J.Pediatr. 1999;135(1):118-121.
  9. Berseth, C. L., Johnston, W. H., Stolz, S. I., Harris, C. L., and Mitmesser, S. H. Clinical response to 2 commonly used switch formulas occurs within 1 day. Clin.Pediatr.(Phila) 2009;48(1):58-65.
  10. Iyngkaran, N., Yadav, M., Looi, L. M., Boey, C. G., Lam, K. L., Balabaskaran, S., and Puthucheary, S. D. Effect of soy protein on the small bowel mucosa of young infants recovering from acute gastroenteritis. J Pediatr.Gastroenterol.Nutr 1988;7(1):68-75.
  11. Halpin, T. C., Byrne, W. J., and Ament, M. E. Colitis, persistent diarrhea, and soy protein intolerance. J Pediatr. 1977;91(3):404-407.
Endometriosis Genitourinary

Orally, soy might increase discomfort during menstrual periods. Evidence from a small, retrospective cohort study has found that consuming soy formula as an infant may slightly increase the duration and discomfort of menstrual periods later in life. However, the investigators noted that these differences may not be clinically significant.

Orally, frequent soy consumption might be a risk factor for uterine leiomyoma, an estrogen-dependent benign tumor located on the uterus. Observational research found that consumption of soy milk or soybean at least four times weekly is associated with a 7-fold increased odds of uterine leiomyoma.

There is some concern that use of soy-based formulas in infants might result in long-term health complications. However, results from a retrospective cohort study has found that intake of soy-based formula as an infant does not affect height, weight, body mass index, pubertal maturation, menstrual history, or pregnancy history, nor does it increase the risk of reproductive organ disorders, hormonal disorders, libido dysfunction, or birth defects in the offspring of adults who received soy formula as infants. Additionally, research in adults shows that urinary phytoestrogens are not associated with endometriosis risk. However, some population research has found that regular exposure to soy-based formulas during infancy is associated with an increased risk for endometriosis.

  1. Strom BL, Schinnar R, Ziegler EE, et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA 2001;286:807-14.
  2. Gao M, Wang H. Frequent milk and soybean consumption are high risks for uterine leiomyoma: A prospective cohort study. Medicine (Baltimore). 2018;97(41):e12009.
  3. Chen A, Rogan WJ. Isoflavones in soy infant formula: a review of evidence for endocrine and other activity in infants. Annu Rev Nutr 2004;24:33-54.
  4. Mumford SL, Weck J, Kannan K, Buck Louis GM. Urinary phytoestrogen concentrations are not associated with incident endometriosis in premenopausal women. J Nutr. 2017;147(2):227-234.
  5. Upson K, Sathyanarayana S, Scholes D, Holt VL. Early-life factors and endometriosis risk. Fertil Steril. 2015;104(4):964-971.e5.
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.

Adverse-effects data: Natural Medicines, Therapeutic Research Center

Dosing

There is no single official dose of soy for any health condition. Amounts used in studies vary widely, and a standardized supplement dose has not been firmly established.

As a food, soy is simply part of a normal diet. For supplements such as isoflavone capsules or soy protein powder, follow the directions on the product label. Because supplement strength and quality can vary, it is best to check with your pharmacist or doctor before starting a concentrated soy supplement, especially if you have a health condition or take other medicines.

Pregnancy & Breastfeeding

Soy & Pregnancy

Likely Safe

When used orally in amounts commonly found in foods.

  1. Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182

Soy & Breastfeeding

Likely Safe

When used orally in amounts commonly found in foods. A single 20-gram dose of roasted soybeans, containing 37 mg isoflavones, produces four to six times less isoflavones in breast milk than provided in a soy-based infant formula. There is insufficient reliable information available about the safety of long-term use of therapeutic amounts of soy during lactation.

  1. Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  2. Franke AA, Custer LJ, Tanaka Y. Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 1998;68:1466-73.
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.

© 2026 Therapeutic Research Center

Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center

References & further reading

The 88 references that drive our Soy monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Franke AA, Custer LJ, Tanaka Y. Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 1998;68:1466-73. PubMed
  2. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11. PubMed
  3. Lu LJ, Anderson KE, Grady JJ, et al. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 2000;60:4112-21.
  4. Pino AM, Valladares LE, Palma MA, et al. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 2000;85:2797-800. DOI
  5. Nisley N, Klepser T. Phytoestrogens for the prevention and treatment of osteoporosis. Alt Med Alert 1999 Dec;138-42.
  6. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998;68:1431S-5S. PubMed
  7. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996;5:785-94.
  8. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90. DOI
  9. Duncan AM, Underhill KE, Xu X, et al. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999;84:3479-84. PubMed
  10. Ginsburg J, Prelevic GM. Lack of significant hormonal effects and controlled trials of phyto-oestrogens. Lancet 2000;355:163-4. PubMed
  11. Anthony MS. Soy and cardiovascular disease: Cholesterol lowering and beyond. J Nutr 2000;130:662S-3S. PubMed
  12. Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999;84:4017-24. DOI
  13. Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 2000;71:1705S-7S. PubMed
  14. Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  15. Codina R, Ardusso L, Lockey RF, et al. Sensitization to soybean hull allergens in subjects exposed to different levels of soybean dust inhalation in Argentina. J Allergy Clin Immunol 2000;105:570-6. PubMed
Keep reading

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Product directory

Supplement products with Soy

1,021 products in our database contain Soy. Open any to see its full ingredient list and every drug interaction we check.

Soy Isoflavones Standardized by Nature's Way Capsule 60 Capsule(s) Off market View ingredients & interactions Soybean by Hawaii Pharm Liquid 4 Fluid Ounce(s) · 120 mL Off market View ingredients & interactions Soybean Non-Alcohol by Hawaii Pharm Liquid 4 Fluid Ounce(s) · 120 mL Off market View ingredients & interactions SpectraSoy by Metagenics Tablet Or Pill 90 Tablet(s) Off market View ingredients & interactions Sterol-Max by Enriching Gifts Capsule 90 Capsule(s) Off market View ingredients & interactions Super Absorbable Soy Isoflavones by Life Extension Capsule 60 Vegetarian Capsule(s) Off market View ingredients & interactions Super Absorbable Soy Isoflavones by Life Extension Capsule 60 Vegetarian Capsule(s) Off market View ingredients & interactions Super Absorbable Soy Isoflavones by Life Extension Capsule 60 Vegetarian Capsule(s) Off market View ingredients & interactions Super Juice by Windmill Health Products Other (e.g. Tea Bag) 60 Caplet(s) Off market View ingredients & interactions Super Osteofood by Higher Nature Tablet Or Pill 90 Tablet(s) Off market View ingredients & interactions Super Osteofood by Higher Nature Tablet Or Pill 90 Tablet(s) Off market View ingredients & interactions Super Osteofood by Higher Nature Tablet Or Pill 90 Tablet(s) Off market View ingredients & interactions Super Osteofood by Higher Nature Tablet Or Pill 90 Tablet(s) Off market View ingredients & interactions Synastat by Sylvan Therapeutics Capsule 120 Capsule(s) · 600 mg Off market View ingredients & interactions Test PCT Ignition by Human Evolution Supplements Capsule 90 Capsule(s) Off market View ingredients & interactions Testralin by Metagenics Tablet Or Pill 60 Tablet(s) Off market View ingredients & interactions Testralin by Metagenics Tablet Or Pill 60 Tablet(s) Off market View ingredients & interactions Testralin by Metagenics Tablet Or Pill 60 Tablet(s) Off market View ingredients & interactions Testralin by Metagenics Tablet Or Pill 60 Tablet(s) Off market View ingredients & interactions Testrogain RX-100 by NewtonEverett Capsule 90 Vegetarian Capsule(s) Off market View ingredients & interactions Testrogain With ZMA by NewtonEverett Capsule 90 Capsule(s) Off market View ingredients & interactions Time Fighters for Men by Physician's Signature Other (e.g. Tea Bag) 120 Caplet(s) Off market View ingredients & interactions True Food All Man by Higher Nature Capsule 30 Capsule(s) Off market View ingredients & interactions True Food All Man by Higher Nature Capsule 30 Capsule(s) Off market View ingredients & interactions
Pharmacist Counseling Corner

Soy: Common Questions

What is Soy used for, and does it work?
People use Soy for many reasons, but the evidence varies by use. According to the Natural Medicines database, there is at least some clinical evidence supporting Soy for Chronic kidney disease (CKD), Diabetes, Diarrhea and Galactosemia. For most other uses it has been studied for, the evidence is currently insufficient to rate. See the graded list on this page, and always confirm with your pharmacist or doctor.
Does Soy interact with prescription medications?
Yes. We list 612 medications with a known interaction with Soy, including 9 rated major. Use the checker above to see how Soy interacts with a specific drug.
How are Soy interactions rated?
Each interaction is graded major, moderate, or minor based on how clinically significant it is and the strength of the evidence behind it. Major interactions are the most serious and are best avoided, or used only under close professional supervision.
Is it safe to take Soy with my medications?
It depends on the specific medication. Some combinations are fine, while others call for monitoring, timing changes, or should be avoided. Check your exact drug above and confirm with your pharmacist or doctor before starting, stopping, or changing anything.
Where does this Soy interaction information come from?
Our interaction data is built on the Natural Medicines database — an evidence-graded reference for vitamins, herbs, and supplements — and is reviewed by licensed HelloPharmacist pharmacists, who may add clinical context.
Is Soy safe to eat every day?
For most people, eating Soy foods like tofu, edamame, and Soy milk daily as part of a balanced diet is considered safe. People with a Soy allergy should avoid it, and those considering high-dose supplements should check with a healthcare provider first.
Does Soy cause breast cancer?
Current research does not show that eating moderate amounts of Soy foods increases breast cancer risk; some studies even suggest it may be neutral or protective. However, the effects of concentrated isoflavone supplements are less clear, so people with hormone-sensitive conditions should talk with their doctor before using them.
Can Soy help with hot flashes during menopause?
Some studies suggest Soy isoflavones may modestly reduce hot flashes in certain women, but the results are mixed and the benefit is often small. It does not work for everyone.
Is Soy a good source of protein?
Yes. Soy is one of the few plant foods that provides complete protein, making it a popular choice for vegetarian and vegan diets.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Have a question about Soy?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist